Additionally, HLH-2004 uses nonspecific parameters that may overlap with other inflammatory conditions or manifestations of lymphoma and overlooks alterations frequently observed in HLH, such as increased transaminase, lactic dehydrogenase, D-dimer, and C-reactive protein levels and neurological manifestations. This evidence concerns the gene CRP and hemophagocytic syndrome.